Update on Biomarkers in Renal Cell Carcinoma – David Braun
Pedro Barata and David Braun delve into the evolving landscape of biomarkers in renal cell carcinoma (RCC). Dr. Braun emphasizes the transition from histological analysis to advanced techniques like genomics and transcriptomics, highlighting their potential to differentiate between molecular subtypes of RCC and predict therapy responses. Specifically, transcriptomics could pave the way for…